ArticleAmerican journal of cancer research2015

Pirarubicin-based chemotherapy displayed better clinical outcomes and lower toxicity than did doxorubicin-based chemotherapy in the treatment of non-metastatic extremity osteosarcoma.

Shuier Zheng et al.PubMed ↗Full text ↗

No numbers read from the abstract.